Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.

Clinical science (London, England : 1979) - 1 Nov 2016

Oliva Iris, Guardiola Montse, Vallvé Joan-Carles, Ibarretxe Daiana, Plana Núria, Masana Lluís, Monk David, Ribalta Josep

Abstract excerpt

Apolipoprotein A5 gene (APOA5) variability explains part of the individual's predisposition to hypertriacylglycerolaemia (HTG). Such predisposition has an inherited component (polymorphisms) and an acquired component regulated by the environment (epigenetic modifications). We hypothesize that the integrated analysis of both components will improve our capacity to estimate APOA5 contribution to HTG. We followed a...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Apolipoprotein A-V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CpG Islands

Share to DNA Methylation

Share to Epigenomics

Share to Hypertriglyceridemia

Share to Polymorphism, Single Nucleotide

Share to Triglycerides

Source

Identifiers

PMID: 27613158
DOI: 10.1042/CS20160433

Genes

APOA5

Variants

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

APOA5 genetic and epigenetic variability jointly regulate circulating triacylglycerol levels.PMID 27613158Read ↗

Characterizing genetic profiles for high triglyceride levels in U.S. patients of African ancestrySemantic proximity Read ↗

Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides.Semantic proximity Read ↗

A promoter variant of the APOA5 gene increases atherogenic LDL levels and arterial stiffness in hypertriglyceridemic patients.Semantic proximity Read ↗

APOA5 Gene Polymorphisms and Cardiovascular Diseases: Metaprediction in Global Populations.Semantic proximity Read ↗

APOA1/C3/A4/A5 Gene Cluster at 11q23.3 and Lipid Metabolism Disorders: From Epigenetic Mechanisms to Clinical PracticesSemantic proximity Read ↗

Epigenetic Patterns in Blood Associated With Lipid Traits Predict Incident Coronary Heart Disease Events and Are Enriched for Results From Genome-Wide Association Studies.Semantic proximity Read ↗

SNPs at the APOA5 gene account for the strong association with hypertriglyceridaemia at the APOA5/A4/C3/A1 locus on chromosome 11q23 in the Northern Irish population.Semantic proximity Read ↗

APOA1/C3/A5 haplotype and risk of hypertriglyceridemia in Taiwanese.Semantic proximity Read ↗

Ancestry-specific profiles of genetic determinants of severe hypertriglyceridemia.Semantic proximity Read ↗

The Apo gene's genetic variants: hidden role in Asian vascular risk.Semantic proximity Read ↗

[Impact of apolipoprotein A5 on cardiovascular risk. Genetic and environmental modulation].Semantic proximity Read ↗

Contribution of APOA5 gene variants to plasma triglyceride determination and to the response to both fat and glucose tolerance challenges.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.